FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044941319> ?p ?o ?g. }

• W2044941319 endingPage "183" @default.
• W2044941319 startingPage "173" @default.
• W2044941319 abstract "The worldwide incidence of rabies and the inability of currently used vaccination strategies to provide highly potent and cost-effective therapy indicate the need for an improved rabies vaccine. Thus, DNA vaccine based on lysosome-targeted gly-coprotein of the rabies virus was evaluated in BALB/c mice. It imparted partial protection (60%) against challenge with 20 LD50 of the challenge virus standard (CVS) strain of rabies virus. To improve the outcome of vaccination, to ultimately enhance the immune response, we investigated different routes for DNA vaccine delivery, varied doses of DNA, and the influence of adjuvant supplementation. The highest immune response pertaining to IgG antibody titer, with a predominantly IgG1/IgG2a subclass distribution, effective cellular immunity, and a high level of rabies virus neutralizing antibodies (RVNAs) was attained by the optimized DNA vaccine formulation comprising intramuscular administration of 100 μg of DNA vaccine supplemented with Emulsi-gen®-D. In preexposure prophylaxis, a 3-dose regimen of this formulation generated a high RVNA titer (32 IU/ml) and conferred complete protection against challenge with 20 LD50 of CVS. For postexposure efficacy analysis, rabies was experimentally induced with 50 LD50 of CVS. Subsequent therapy with 5 doses of the formulation completely prevented rabies in BALB/c mice, which maintained protective RVNA titers of 4 IU/ml. The World Health Organization recommended rabies protective titer threshold is 0.5 IU/ml. Thus, this optimized DNA vaccine formulation provides an avenue for preventing and controlling rabies.—Kaur, M., Saxena, A., Rai, A., and Bhatnagar, R. Rabies DNA vaccine encoding lyso-some-targeted glycoprotein supplemented with Emulsi-gen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. FASEB J. 24, 173–183 (2010). www.fasebj.org" @default.
• W2044941319 created "2016-06-24" @default.
• W2044941319 creator A5015254541 @default.
• W2044941319 creator A5037894473 @default.
• W2044941319 creator A5044339031 @default.
• W2044941319 creator A5054202422 @default.
• W2044941319 date "2009-09-09" @default.
• W2044941319 modified "2023-10-16" @default.
• W2044941319 title "Rabies DNA vaccine encoding lysosome‐targeted glycoprotein supplemented with Emulsigen‐D confers complete protection in preexposure and postexposure studies in BALB/c mice" @default.
• W2044941319 cites W1535836870 @default.
• W2044941319 cites W1543460784 @default.
• W2044941319 cites W1971308941 @default.
• W2044941319 cites W1973493403 @default.
• W2044941319 cites W1974630398 @default.
• W2044941319 cites W1976709306 @default.
• W2044941319 cites W1976943109 @default.
• W2044941319 cites W1978826340 @default.
• W2044941319 cites W1979237882 @default.
• W2044941319 cites W1980879199 @default.
• W2044941319 cites W1982433004 @default.
• W2044941319 cites W1986814564 @default.
• W2044941319 cites W1989477774 @default.
• W2044941319 cites W1993964853 @default.
• W2044941319 cites W1994841440 @default.
• W2044941319 cites W1999625461 @default.
• W2044941319 cites W2002022916 @default.
• W2044941319 cites W2014495927 @default.
• W2044941319 cites W2022945245 @default.
• W2044941319 cites W2028203532 @default.
• W2044941319 cites W2035910031 @default.
• W2044941319 cites W2036562414 @default.
• W2044941319 cites W2043813518 @default.
• W2044941319 cites W2056941030 @default.
• W2044941319 cites W2063756788 @default.
• W2044941319 cites W2083679701 @default.
• W2044941319 cites W2085550825 @default.
• W2044941319 cites W2088075332 @default.
• W2044941319 cites W2090978046 @default.
• W2044941319 cites W2129569261 @default.
• W2044941319 cites W2132042285 @default.
• W2044941319 cites W2132568167 @default.
• W2044941319 cites W2137210215 @default.
• W2044941319 cites W2143209582 @default.
• W2044941319 cites W2151441310 @default.
• W2044941319 cites W2157159164 @default.
• W2044941319 cites W2159596715 @default.
• W2044941319 cites W2177193625 @default.
• W2044941319 cites W2177385981 @default.
• W2044941319 doi "https://doi.org/10.1096/fj.09-138644" @default.
• W2044941319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19741168" @default.
• W2044941319 hasPublicationYear "2009" @default.
• W2044941319 type Work @default.
• W2044941319 sameAs 2044941319 @default.
• W2044941319 citedByCount "30" @default.
• W2044941319 countsByYear W20449413192012 @default.
• W2044941319 countsByYear W20449413192013 @default.
• W2044941319 countsByYear W20449413192014 @default.
• W2044941319 countsByYear W20449413192015 @default.
• W2044941319 countsByYear W20449413192016 @default.
• W2044941319 countsByYear W20449413192017 @default.
• W2044941319 countsByYear W20449413192018 @default.
• W2044941319 countsByYear W20449413192020 @default.
• W2044941319 countsByYear W20449413192021 @default.
• W2044941319 countsByYear W20449413192022 @default.
• W2044941319 countsByYear W20449413192023 @default.
• W2044941319 crossrefType "journal-article" @default.
• W2044941319 hasAuthorship W2044941319A5015254541 @default.
• W2044941319 hasAuthorship W2044941319A5037894473 @default.
• W2044941319 hasAuthorship W2044941319A5044339031 @default.
• W2044941319 hasAuthorship W2044941319A5054202422 @default.
• W2044941319 hasConcept C109663412 @default.
• W2044941319 hasConcept C159047783 @default.
• W2044941319 hasConcept C167508917 @default.
• W2044941319 hasConcept C203014093 @default.
• W2044941319 hasConcept C22070199 @default.
• W2044941319 hasConcept C22889606 @default.
• W2044941319 hasConcept C2522874641 @default.
• W2044941319 hasConcept C2776849203 @default.
• W2044941319 hasConcept C2777863537 @default.
• W2044941319 hasConcept C2777961786 @default.
• W2044941319 hasConcept C2777974785 @default.
• W2044941319 hasConcept C2779261636 @default.
• W2044941319 hasConcept C2779341262 @default.
• W2044941319 hasConcept C2779811178 @default.
• W2044941319 hasConcept C2780674857 @default.
• W2044941319 hasConcept C2780801004 @default.
• W2044941319 hasConcept C32611913 @default.
• W2044941319 hasConcept C71924100 @default.
• W2044941319 hasConcept C86803240 @default.
• W2044941319 hasConcept C8891405 @default.
• W2044941319 hasConceptScore W2044941319C109663412 @default.
• W2044941319 hasConceptScore W2044941319C159047783 @default.
• W2044941319 hasConceptScore W2044941319C167508917 @default.
• W2044941319 hasConceptScore W2044941319C203014093 @default.
• W2044941319 hasConceptScore W2044941319C22070199 @default.
• W2044941319 hasConceptScore W2044941319C22889606 @default.
• W2044941319 hasConceptScore W2044941319C2522874641 @default.
• W2044941319 hasConceptScore W2044941319C2776849203 @default.

• next